<DOC>
	<DOCNO>NCT01783821</DOCNO>
	<brief_summary>This study test whether inhaled budesonide formoterol able alleviate prevent pulmonary injury administer early hospital course patient risk develop acute respiratory distress syndrome ( ARDS ) . The FDA approve many us budesonide formoterol , include asthma chronic obstructive pulmonary disease ( COPD ) , use two drug experimental ARDS .</brief_summary>
	<brief_title>LIPS-B : Lung Injury Prevention Study With Budesonide Beta</brief_title>
	<detailed_description>Subjects randomize either placebo combine standard aerosolize dos budesonide ( 0.5 mg ) formoterol ( 20 mcg ) twice daily , least 6 hour dos , 5 calendar day total 10 dos hospital discharge death . Local hospital pharmacy prepare identical appear solution drug deliver respiratory therapist blind randomization use standard jet nebulizer produce aerosol particle size within respirable range ( &lt; 5.5 micron ) . The first dose administer within 4 hour randomization .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Adult patient ( age &gt; 18 ) Admitted hospital emergency department ( ED ) High risk develop ARDS ( Lung Injury Prediction Score ( LIPS ) great equal four ) Inhaled corticosteroid and/or beta agonist treatment admission within 7 day prior admission ( history asthma COPD necessitate therapy ) Chronic pulmonary disease require daytime oxygen supplementation therapy Systemic steroid treatment admission within 7 day prior admission equivalent 5 mg prednisone daily Inability obtain consent within 12 hour hospital presentation Acute lung injury prior randomization Receiving mechanical ventilation current hospital admission ( patient ventilator dependent ) Presentation believe purely due heart failure without know risk factor ARDS Allergy contraindication either budesonide and/or formoterol use Expected hospital stay and/or survival &lt; 48 hour admission comfort hospice care Patient , surrogate physician commit full support ( exception : patient exclude he/she would receive supportive care except attempt resuscitation cardiac arrest ) Previous enrollment trial . Coenrollment LIPSA trial allow . An active enrollment concomitant trial judge case case basis PIs trial . EKG and/or clinical presentation suggestive acute coronary ischemia New onset cardiac arrhythmia Current atrial fibrillation ventricular rate &gt; 110/minute Persistent sinus tachycardia &gt; 130/minute despite early goal direct therapy fluid , pressor , antibiotic supplemental oxygen Pregnant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Acute respiratory distress syndrome ( ARDS )</keyword>
</DOC>